KyungdongPharm
Founded in 1976, Kyungdong Pharm produces prescription drugs including Duorovan and Baldipine, and launched the health-food brand WIAVIM.
As of 2026-10-11, KyungdongPharm has 346 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1976 and listed on KOSDAQ in 1992, Kyungdong Pharm is a pharmaceutical company. Its product sales are led by Duorovan tablets and merchandise sales by Alphortin soft capsules, covering ETC drugs for the cardiovascular, digestive, and respiratory systems, and it launched the health functional food brand WIAVIM. The pharmaceutical segment accounts for about 95% of revenue (about 64% product sales, 28% merchandise sales) and leasing/other segments about 5%, with the domestic market making up most sales and exports at about 1%.
Products & technology
- Duorovan Tab.
- Alphortin Soft Cap.
- Baldipine Tab.
- Atrovan Tab.
- WIAVIMHealth functional food brand
Regulatory approvals
data.go.kr346 Korean MFDS drug approvals · 1976–2026
- MFDS drugRAMON Prefilled Inj.2026-07-24Drug · Prescription · Approval202602138
- MFDS drugKotuluten Tab.2026-05-14Drug · OTC · Notification202601427
- MFDS drugVonost Tab. 20mg2026-04-23Drug · Prescription · Approval202601200
- MFDS drugVonost Tab. 10mg2026-04-23Drug · Prescription · Approval202601201
- MFDS drugAny Coin Hot&Cool Plaster2026-01-02Drug · OTC · Notification202600001
- MFDS drugFenorovan Tab. 2/145mg(Pitavastatin calcium, Fenofibrate)2025-12-09Drug · Prescription · Approval202503209
- MFDS drugValdipine Plus Tab. 5/80/12.5mg2025-11-07Drug · Prescription · Approval202502890
- MFDS drugValdipine Plus Tab. 5/160/12.5mg2025-11-07Drug · Prescription · Approval202502891
- MFDS drugValdipine Plus Tab. 10/160/25mg2025-11-07Drug · Prescription · Approval202502892
- MFDS drugValdipine Plus Tab. 10/160/12.5mg2025-11-07Drug · Prescription · Approval202502893
- MFDS drugGbam-N Soft Cap.2025-08-08Drug · OTC · Notification202502075
- MFDS drugTelcardin Tab. 20mg2025-04-14Drug · Prescription · Approval202500867
Show 68 more
- MFDS drugTegozan Tab. 50mg2025-04-01Drug · Prescription · Approval202500754
- MFDS drugTegozan Tab. 25mg2025-04-01Drug · Prescription · Approval202500755
- MFDS drugDapazinSM SR. 5/50/1000mg2025-03-27Drug · Prescription · Approval202500710
- MFDS drugRotodipin Tab. 5/5mg(Rosuvastatin, Amlodipine)2025-03-18Drug · Prescription · Approval202500591
- MFDS drugRotodipin Tab. 20/5mg(Rosuvastatin, Amlodipine)2025-03-18Drug · Prescription · Approval202500592
- MFDS drugRotodipin Tab. 10/5mg(Rosuvastatin, Amlodipine)2025-03-18Drug · Prescription · Approval202500593
- MFDS drugNasopra Tab.500/20mg(Naproxen, Esomeprazole)2025-02-26Drug · Prescription · Approval202500425
- MFDS drugDapazinSM SR. 10/100/1000mg2024-12-31Drug · Prescription · Approval202403108
- MFDS drugDapazin Tab. 5mg2024-11-19Drug · Prescription · Approval202402722
- MFDS drugGinkgoB Tab. 240mg2024-10-18Drug · OTC · Notification202402458
- MFDS drugKD Peramivir Inj.2024-10-04Drug · Prescription · Approval202402371
- MFDS drugDuvalcan Tab. 0.2mg(Dutasteride)2024-07-25Drug · Prescription · Approval202401803
- MFDS drugKD Nicergoline Tab. 30mg(Nicergoline)2024-02-29Drug · Prescription · Approval202400423
- MFDS drugChirex Tab. 600mg2024-02-29Drug · OTC · Notification202400435
- MFDS drugLitamezin SR Tab. 5/1000mg(Linagliptin,Metformin HCl)2024-01-24Drug · Prescription · Approval202400184
- MFDS drugLitamezin SR Tab. 2.5/1000mg(Linagliptin,Metformin HCl)2024-01-24Drug · Prescription · Approval202400185
- MFDS drugGnal-N Cough A Soft Cap.2023-10-19Drug · OTC · Notification202302948
- MFDS drugGnal-N Cold A Soft Cap.2023-10-19Drug · OTC · Notification202302949
- MFDS drugGnal-N Nose A Soft Cap.2023-09-12Drug · OTC · Notification202302739
- MFDS drugKotuluten Nasal Spray2023-08-21Drug · OTC · Notification202302474
- MFDS drugSelecaduo Tab.2023-08-10Drug · Prescription · Approval202302407
- MFDS drugGnal-N Ace Soft Cap.2023-07-12Drug · OTC · Notification202302140
- MFDS drugDapazin-S duo Tab. 10/100mg(Dapagliflozin, Sitagliptin)2023-06-15Drug · Prescription · Approval202301844
- MFDS drugVitaBcare Tab.2023-04-19Drug · OTC · Notification202301278
- MFDS drugDapamepi Tab. 10/4mg2023-02-28Drug · Prescription · Approval202300717
- MFDS drugPiroxica Gel2022-11-02Drug · OTC · Notification202203980
- MFDS drugFineback Tab.2022-07-27Drug · OTC · Notification202203104
- MFDS drugKD Jahager Inj2022-07-07Drug · Prescription · Approval202202852
- MFDS drugTenelyM SR Tab. 20/1000mg2022-07-06Drug · Prescription · Approval202202805
- MFDS drugTenelyM SR Tab. 10/750mg2022-07-06Drug · Prescription · Approval202202806
- MFDS drugTenelyM SR Tab. 10/500mg2022-07-06Drug · Prescription · Approval202202807
- MFDS drugKD Rebamide Tab.2022-05-23Drug · Prescription · Approval202202170
- MFDS drugMagNneu Soft Cap.2022-05-19Drug · OTC · Notification202202104
- MFDS drugCeftoren Tab. 100mg2022-03-29Drug · Prescription · Approval202201222
- MFDS drugDapamet SR Tab. 10/500mg2021-12-23Drug · Prescription · Approval202108077
- MFDS drugDapamet SR Tab. 10/1000mg2021-12-23Drug · Prescription · Approval202108078
- MFDS drugKyungdong Panthenol Ointment2021-11-30Drug · OTC · Notification202107682
- MFDS drugGnal-N W Soft Cap.2021-11-08Drug · OTC · Notification202107347
- MFDS drugAmycin Tab. 250mg(Azithromycin Hydrate)2021-10-28Drug · Prescription · Approval202107186
- MFDS drugKyungdong Fanitine Tab. 10mg (Famotidine)2021-08-19Drug · OTC · Notification202106054
- MFDS drugLibantil Tab. 15mg2021-06-29Drug · Prescription · Approval202104937
- MFDS drugLibantil Tab. 20mg2021-06-29Drug · Prescription · Approval202104938
- MFDS drugRablon SR Tab. 50mg2021-02-18Drug · Prescription · Approval202101477
- MFDS drugEsocarbo tab. 20/600mg2021-02-05Drug · Prescription · Approval202101156
- MFDS drugEsocarbo tab. 40/600mg2021-02-05Drug · Prescription · Approval202101157
- MFDS drugAtorvzet Tab 10/10mg2021-01-08Drug · Prescription · Approval202100186
- MFDS drugAtorvzet Tab 10/20mg2021-01-08Drug · Prescription · Approval202100187
- MFDS drugAtorvzet Tab 10/40mg2021-01-08Drug · Prescription · Approval202100188
- MFDS drugMegarovan Soft Cap. 5/1000mg2020-12-01Drug · Prescription · Approval202008416
- MFDS drugNewmona Tab.Revoked2020-10-19Drug · OTC · Notification202007137
- MFDS drugValtrio Tab. 5/80/10mg2020-09-29Drug · Prescription · Approval202006708
- MFDS drugValtrio Tab. 5/160/10mg2020-09-29Drug · Prescription · Approval202006709
- MFDS drugValtrio Tab. 10/160/10mg2020-09-29Drug · Prescription · Approval202006710
- MFDS drugValtrio Tab. 10/160/20mg2020-09-29Drug · Prescription · Approval202006711
- MFDS drugTenelitin Tab. 20mg2020-09-04Drug · Prescription · Approval202006180
- MFDS drugEpastine Tab2020-05-26Drug · Prescription · Approval202003826
- MFDS drugDapazin Tab. 10mg2020-05-22Drug · Prescription · Approval202003739
- MFDS drugDurocan Tab. 0.5mg2020-05-22Drug · Prescription · Approval202003741
- MFDS drugVinitis Cap.2020-05-22Drug · OTC · Notification202003766
- MFDS drugUronal SR Tab. 0.4mg2020-04-24Drug · Prescription · Approval202003007
- MFDS drugGaspren CR Tab. 15mg2020-04-24Drug · Prescription · Approval202003034
- MFDS drugUrimoQ Tab. 0.1mg2020-04-23Drug · Prescription · Approval202002926
- MFDS drugUrimoQ Tab. 0.2mg2020-04-23Drug · Prescription · Approval202002927
- MFDS drugBazetop Tab. 20mg2020-04-22Drug · Prescription · Approval202002843
- MFDS drugEldoral Cap.2020-04-02Drug · OTC · Notification202002320
- MFDS drugAny Cure Ointment2020-03-24Drug · OTC · Notification202002056
- MFDS drugCaldione Tab2020-03-04Drug · OTC · Notification202001517
- MFDS drugDonepem Tab. 5mg2020-02-27Drug · Prescription · Approval202001374
Showing the 80 most recent of 346 records.
Clinical trials
data.go.kr76 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 53 · Phase 1 20 · Phase 3 3)
- BioequivalenceKD24072026-07-22
2 trial sites
- Bioequivalence유로날서방정0.4밀리그램(탐스로신염산염)2026-06-16
2 trial sites
- Bioequivalence유로날서방정0.4밀리그램(탐스로신염산염)2026-06-16
2 trial sites
- Bioequivalence로니틴서방정75밀리그램(록사티딘아세테이트염산염75밀리그램)2026-06-15
2 trial sites
- Bioequivalence로니틴서방정75밀리그램(록사티딘아세테이트염산염75밀리그램)2026-06-12
2 trial sites
- BioequivalenceKD25082026-06-02
2 trial sites
- BioequivalenceKD25082026-06-02
2 trial sites
- BioequivalenceKD23032026-05-15
2 trial sites
- Phase 1KDF19052026-03-25
2 trial sites
- Phase 1KDF19052026-03-25
2 trial sites
- BioequivalenceKD22012024-12-27
2 trial sites
- BioequivalenceKD22012024-12-26
2 trial sites
Show 64 more
- Phase 1KDF19052024-12-20
2 trial sites
- Phase 1KDF19052024-12-20
2 trial sites
- Phase 1KDF19052023-12-28
2 trial sites
- Phase 1KDF19052023-12-28
2 trial sites
- BioequivalenceKD21022023-09-26
1 trial site
- Bioequivalence경동니세르골린정30밀리그램2023-05-15
1 trial site
- Bioequivalence나소프라정500/20밀리그램2022-11-09
1 trial site
- Bioequivalence나소프라정500/20밀리그램2022-11-09
1 trial site
- Phase 1몬테시엘정2022-07-14
1 trial site
- Phase 1KDF20012022-02-11
1 trial site
- Phase 3KDF19012022-01-18
26 trial sites
- Bioequivalence올로디핀정10/40밀리그램(암로디핀베실산염/올메사르탄메독소밀)2021-12-08
2 trial sites
- Bioequivalence나소프라정500/20밀리그램2021-10-08
1 trial site
- Bioequivalence유로스칸정(피나스테리드)2021-09-29
1 trial site
- Bioequivalence로트로반정10밀리그램(로수바스타틴칼슘)2021-09-13
2 trial sites
- Bioequivalence베프졸정20밀리그램2021-09-01
1 trial site
- BioequivalenceKDP21012021-06-03
1 trial site
- Phase 1KDF19012021-06-03
2 trial sites
- Bioequivalence듀오로반정10/10밀리그램2021-04-29
2 trial sites
- Phase 3KDF19052021-03-25
25 trial sites
- Bioequivalence아마이신정250밀리그램(아지트로마이신수화물)2020-10-23
1 trial site
- Bioequivalence세프토렌정100밀리그램(세프디토렌피복실)2020-10-21
1 trial site
- Phase 1KD40022020-08-28
1 trial site
- Phase 1KD40022020-07-24
1 trial site
- Bioequivalence리반틸정20밀리그램(리바록사반)2020-05-15
1 trial site
- BioequivalenceAD1062020-05-13
2 trial sites
- Phase 1KDF19012020-05-13
1 trial site
- Phase 1KDF19052020-04-13
1 trial site
- Bioequivalence라블론서방정50밀리그램(미라베그론)2020-01-28
2 trial sites
- Bioequivalence아마이신정250밀리그램(아지트로마이신수화물)2019-11-04
2 trial sites
- Bioequivalence덱시디펜정400밀리그램(덱시부프로펜디.씨)2019-08-19
2 trial sites
- Bioequivalence유로날서방정0.4밀리그램(탐스로신염산염)2019-06-24
2 trial sites
- Bioequivalence유로날서방정0.4밀리그램(탐스로신염산염)2019-06-20
2 trial sites
- Bioequivalence피트로반정2밀리그램(피타바스타틴칼슘수화물)2019-06-04
2 trial sites
- Phase 1KD50012019-05-24
1 trial site
- Bioequivalence로사졸씨알정200밀리그램(실로스타졸)2019-04-08
1 trial site
- Bioequivalence로사졸씨알정200밀리그램(실로스타졸)2019-04-05
2 trial sites
- Bioequivalence세프토렌정100밀리그램(세프디토렌피복실)2019-03-27
1 trial site
- Phase 1KD40042019-01-25
2 trial sites
- Bioequivalence라블론서방정50밀리그램(미라베그론)2019-01-08
2 trial sites
- Bioequivalence라블론서방정50밀리그램(미라베그론)2019-01-07
2 trial sites
- Phase 1다파진정10밀리그램(KD4003)2018-11-05
1 trial site
- Phase 1테네리틴정20밀리그램2018-09-18
1 trial site
- Bioequivalence펙소트정80밀리그램(페북소스타트)2018-07-10
2 trial sites
- Bioequivalence뉴카펜캡슐150밀리그램2017-10-26
2 trial sites
- Phase 3KD50012017-08-14
15 trial sites
- Phase 1레니코정(KD8001)2017-06-22
1 trial site
- Bioequivalence헤비콤캡슐2017-05-22
2 trial sites
- Bioequivalence리타메진정2.5/1000밀리그램2017-01-18
2 trial sites
- Bioequivalence베포리진정10밀리그램(베포타스틴베실산염)2017-01-16
2 trial sites
- Bioequivalence픽토민정15/850밀리그램2017-01-13
1 trial site
- Bioequivalence리타진정(리나글립틴)2016-11-11
2 trial sites
- Bioequivalence비야플루캡슐75밀리그램(오셀타미비르인산염)2016-10-26
2 trial sites
- Phase 1KD50012016-08-08
1 trial site
- Bioequivalence솔페신정10밀리그램(솔리페나신숙신산염)2015-10-14
2 trial sites
- Phase 1KD50012015-06-29
1 trial site
- Bioequivalence시알스타정5밀리그램2014-12-29
2 trial sites
- Bioequivalence시알스타정20밀리그램2014-12-24
2 trial sites
- Bioequivalence셀렉카정(세레콕시브)2014-03-07
2 trial sites
- Bioequivalence헤다크캡슐(플루나리진염산염)2013-12-27
2 trial sites
- Bioequivalence셀렉카캡슐200밀리그램(세레콕시브)2013-10-29
2 trial sites
- Bioequivalence리팍스정(리팍시민)2013-08-19
2 trial sites
- Bioequivalence레시프람정(에스시탈로프람옥살산염)2013-07-31
2 trial sites
- Bioequivalence발디핀정 10/160밀리그램2012-07-27
2 trial sites
R&D and key agreements
Source: DART corporate disclosure순환기계용제·협압강하제·당뇨치료제 복합제형 개발 · 순환기계·당뇨 · Focused R&D on combination formulations for the domestic cardiovascular and diabetes markets
Patents
KIPRIS · applicant-matchedRejected · 2023-07 · Application 1020230085957
Rejected · 2021-04 · Application 1020210047611
Registered · 2019-01 · Application 1020190010132
Registered · 2016-11 · Application 1020160152680
Registered · 2016-10 · Application 1020160134859
Registered · 2015-10 · Application 1020150150678
Registered · 2015-06 · Application 1020150085346
Registered · 2015-06 · Application 1020150078483
Registered · 2012-03 · Application 1020120031492
Registered · 2010-02 · Application 1020100009168
Show 41 more patents
Rejected · 2010-01 · Application 1020100001519
Withdrawn · 2010-01 · Application 1020100001520
Registered · 2007-05 · Application 1020070044433
Registered · 2006-12 · Application 1020060134459
Expired · 2006-02 · Application 1020060011703
Expired · 2006-01 · Application 1020060003393
Expired · 2005-04 · Application 1020050031820
Expired · 2004-04 · Application 1020040023668
Rejected · 2003-11 · Application 1020030083645
Expired · 2003-07 · Application 1020030048967
Expired · 2003-06 · Application 1020030038417
Withdrawn · 2003-01 · Application 1020030004225
Rejected · 2002-11 · Application 1020020071924
Expired · 2002-10 · Application 1020020059879
Expired · 2002-07 · Application 1020020041267
Expired · 2002-07 · Application 1020020040325
Expired · 2002-07 · Application 1020020040324
Expired · 2002-06 · Application 1020020031668
Expired · 2002-02 · Application 1020020008829
Expired · 2001-12 · Application 1020010084351
Expired · 2001-09 · Application 1020010058257
Expired · 2001-07 · Application 1020010043741
Rejected · 2001-02 · Application 1020010008408
Expired · 2000-10 · Application 1020000058050
Expired · 2000-05 · Application 1020000029739
Expired · 2000-02 · Application 1020000010161
Expired · 2000-02 · Application 1020000005930
Withdrawn · 1999-08 · Application 1019990035746
Expired · 1999-08 · Application 1019990034792
Expired · 1999-08 · Application 1019990034794
Expired · 1999-08 · Application 1019990034793
Rejected · 1999-06 · Application 1019990024780
Expired · 1999-05 · Application 1019990018640
Expired · 1999-04 · Application 1019990014715
Expired · 1999-04 · Application 1019990014714
Expired · 1999-03 · Application 1019990007480
Expired · 1999-02 · Application 1019990004468
Expired · 1999-02 · Application 1019990004469
Rejected · 1998-05 · Application 1019980017225
Expired · 1998-05 · Application 1019980016567
Expired · 1992-07 · Application 1019920012629
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive2
- OpenAIOAI-SearchBot38
- MicrosoftBingbot2
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for KyungdongPharm and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1978 and listed on the KOSDAQ in 2000, Jin Yang Pharmaceutical is a generic-drug-focused pharmaceutical company producing Sobunal and Octiran.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition